Jiaheng Qiu

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

David F. McDermott, Mahrukh Huseni, Michael B. Atkins et al. · Nature Medicine · 2018 · 1.2K citations · Full text

Urology, Genitourinary Cancer, Medicine +9

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH)

Solange Peters, Scott Gettinger, Melissa L. Johnson et al. · Journal of Clinical Oncology · 2017 · 415 citations · Full text

Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant

Jill M. Spoerke, Steven Gendreau, Kimberly Walter et al. · Nature Communications · 2016 · 292 citations · Full text

Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial

Ian E. Krop, Ingrid A. Mayer, Vinod Ganju et al. · The Lancet Oncology · 2016 · 288 citations

Metastatic Breast Cancer, Oncology, Breast Oncology +8

Childhood Cancer and Traffic-Related Air Pollution Exposure in Pregnancy and Early Life

Julia E. Heck, Jun Wu, Christina Lombardi et al. · Environmental Health Perspectives · 2013 · 138 citations · Full text